{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:01:51Z","timestamp":1769691711393,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-025-02783-9","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T16:32:51Z","timestamp":1766680371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of failure analysis and the role of consolidative thoracic radiotherapy in extensive\u2011stage small\u2011cell lung cancer treated with first\u2011line chemoimmunotherapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Aihua","family":"Lan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"2783_CR1","doi-asserted-by":"publisher","first-page":"215719","DOI":"10.1016\/j.canlet.2022.215719","volume":"541","author":"Y Tian","year":"2022","unstructured":"Tian Y, Ma J, Jing X, Zhai X, Li Y, Guo Z, Yu J, Zhu H. Radiation therapy for extensive-stage small-cell lung cancer in the era of immunotherapy. Cancer Lett. 2022;541:215719.","journal-title":"Cancer Lett"},{"issue":"8","key":"2783_CR2","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/cncr.23361","volume":"112","author":"T Seute","year":"2008","unstructured":"Seute T, Leffers P, ten Velde GP, Twijnstra A. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI). Cancer. 2008;112(8):1827\u201334.","journal-title":"Cancer"},{"issue":"5","key":"2783_CR3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","volume":"18","author":"T Takahashi","year":"2017","unstructured":"Takahashi T, Yamanaka T, Seto T, Harada H, Nokihara H, Saka H, Nishio M, Kaneda H, Takayama K, Ishimoto O, et al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2017;18(5):663\u201371.","journal-title":"Lancet Oncol"},{"issue":"14","key":"2783_CR4","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1200\/JCO.2011.40.4905","volume":"30","author":"A Rossi","year":"2012","unstructured":"Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Fr\u00fch M, Qian W, Tamura T, Samantas E, et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncology: Official J Am Soc Clin Oncol. 2012;30(14):1692\u20138.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"6","key":"2783_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1200\/JCO.20.01055","volume":"39","author":"SV Liu","year":"2021","unstructured":"Liu SV, Reck M, Mansfield AS, Mok T, Scherpereel A, Reinmuth N, Garassino MC, De Castro Carpeno J, Califano R, Nishio M, et al. Updated overall survival and PD-L1 subgroup analysis of patients with Extensive-Stage Small-Cell lung cancer treated with Atezolizumab, Carboplatin, and Etoposide (IMpower133). J Clin Oncology: Official J Am Soc Clin Oncol. 2021;39(6):619\u201330.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"1","key":"2783_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(20)30539-8","volume":"22","author":"JW Goldman","year":"2021","unstructured":"Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, \u00d6zg\u00fcro\u011flu M, Ji JH, et al. Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):51\u201365.","journal-title":"Lancet Oncol"},{"issue":"12","key":"2783_CR7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/jama.2022.16464","volume":"328","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Han L, Wu L, Chen J, Sun H, Wen G, Ji Y, Dvorkin M, Shi J, Pan Z, et al. Effect of First-Line Serplulimab vs placebo added to chemotherapy on survival in patients with Extensive-Stage small cell lung cancer: the ASTRUM-005 randomized clinical trial. JAMA. 2022;328(12):1223\u201332.","journal-title":"JAMA"},{"issue":"9962","key":"2783_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","volume":"385","author":"BJ Slotman","year":"2015","unstructured":"Slotman BJ, van Tinteren H, Praag JO, Knegjens JL, El Sharouni SY, Hatton M, Keijser A, Faivre-Finn C, Senan S. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet. 2015;385(9962):36\u201342.","journal-title":"Lancet"},{"issue":"6","key":"2783_CR9","first-page":"100330","volume":"3","author":"Y Chen","year":"2022","unstructured":"Chen Y, Paz-Ares L, Reinmuth N, Garassino MC, Statsenko G, Hochmair MJ, \u00d6zg\u00fcro\u011flu M, Verderame F, Havel L, Losonczy G, et al. Impact of brain metastases on treatment patterns and outcomes with First-Line durvalumab plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A brief report. JTO Clin Res Rep. 2022;3(6):100330.","journal-title":"JTO Clin Res Rep"},{"issue":"5","key":"2783_CR10","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.ijrobp.2020.09.020","volume":"108","author":"KA Higgins","year":"2020","unstructured":"Higgins KA, Curran WJ Jr., Liu SV, Yu W, Brockman M, Johnson A, Bara I, Bradley JD. Patterns of disease progression after Carboplatin\/Etoposide\u2009+\u2009Atezolizumab in Extensive-Stage Small-Cell lung cancer (ES-SCLC). Int J Radiat Oncol Biol Phys. 2020;108(5):1398.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2783_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/cncr.35003","volume":"130","author":"S Lu","year":"2024","unstructured":"Lu S, Guo X, Li Y, Liu H, Zhang Y, Zhu H. Antiprogrammed death ligand 1 therapy failed to reduce the risk of developing brain metastases in patients with extensive-stage small cell lung cancer: A retrospective analysis. Cancer. 2024;130(1):18\u201330.","journal-title":"Cancer"},{"issue":"1","key":"2783_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12931-025-03157-1","volume":"26","author":"B Huang","year":"2025","unstructured":"Huang B, Liu S, Wang K, Zhao J, Li M, Wang X, Wang W, Wang X, Yu J, Meng X, et al. Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis. Respir Res. 2025;26(1):85.","journal-title":"Respir Res"},{"issue":"10","key":"2783_CR13","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.21037\/tlcr-23-294","volume":"12","author":"Z Cai","year":"2023","unstructured":"Cai Z, Gu X, Xie J, Cheng D, Chen J, Cheng J, Ye J, Lv T. Safety and efficacy of thoracic radiotherapy combined with chemo-immunotherapy in patients with extensive-stage small cell lung cancer: a multicenter retrospective analysis. Transl Lung Cancer Res. 2023;12(10):1987\u20132000.","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"2783_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12672-023-00666-7","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Jing W, Jing X, Sun Y, Tang X, Guo J, Zhang Y, Zhu H. Role of consolidative thoracic radiation in extensive-stage small-cell lung cancer with first-line chemoimmunotherapy: a retrospective study from a single cancer center. Discov Oncol. 2023;14(1):55.","journal-title":"Discov Oncol"},{"key":"2783_CR15","doi-asserted-by":"publisher","first-page":"1289434","DOI":"10.3389\/fimmu.2023.1289434","volume":"14","author":"V Longo","year":"2023","unstructured":"Longo V, Della Corte CM, Russo A, Spinnato F, Ambrosio F, Ronga R, Marchese A, Del Giudice T, Sergi C, Casaluce F, et al. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy. Front Immunol. 2023;14:1289434.","journal-title":"Front Immunol"},{"issue":"1","key":"2783_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13014-023-02308-2","volume":"18","author":"J Peng","year":"2023","unstructured":"Peng J, Zhang L, Wang L, Feng H, Yao D, Meng R, Liu X, Li X, Liu N, Tan B, et al. Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer. Radiat Oncol. 2023;18(1):111.","journal-title":"Radiat Oncol"},{"key":"2783_CR17","doi-asserted-by":"crossref","unstructured":"Xie Z, Liu J, Wu M, Wang X, Lu Y, Han C, Cong L, Li J, Meng X. Real-world efficacy and safety of thoracic radiotherapy after first-line chemo-immunotherapy in extensive-stage small-cell lung cancer. J Clin Med. 2023;12(11).","DOI":"10.3390\/jcm12113828"},{"issue":"1","key":"2783_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13014-024-02420-x","volume":"19","author":"Y Yao","year":"2024","unstructured":"Yao Y, Li B, Song R, Yang L, Zou B, Wang L. Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis. Radiat Oncol. 2024;19(1):25.","journal-title":"Radiat Oncol"},{"key":"2783_CR19","doi-asserted-by":"publisher","first-page":"110014","DOI":"10.1016\/j.radonc.2023.110014","volume":"190","author":"B Feng","year":"2024","unstructured":"Feng B, Zheng Y, Zhang J, Tang M, Na F. Chemoimmunotherapy combined with consolidative thoracic radiotherapy for extensive-stage small cell lung cancer: A systematic review and meta-analysis. Radiother Oncol. 2024;190:110014.","journal-title":"Radiother Oncol"},{"key":"2783_CR20","doi-asserted-by":"publisher","first-page":"115592","DOI":"10.1016\/j.ejca.2025.115592","volume":"225","author":"F Monaca","year":"2025","unstructured":"Monaca F, Gomez-Randulfe I, Walls G, Cantale O, Parreira A, Polidori S, Di Salvatore M, Longo V, Galetta D, Vita E, et al. Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis. Eur J Cancer. 2025;225:115592.","journal-title":"Eur J Cancer"},{"issue":"17","key":"2783_CR21","doi-asserted-by":"publisher","first-page":"e70175","DOI":"10.1002\/cam4.70175","volume":"13","author":"X Mu","year":"2024","unstructured":"Mu X, Zhou Y, Liu Q, Wang J, Xu F, Luo F, Wang K, Li L, Tian P, Li Y, et al. Impact of thoracic radiotherapy on first-line treatment outcomes in ES-SCLC patients. Cancer Med. 2024;13(17):e70175.","journal-title":"Cancer Med"},{"issue":"2","key":"2783_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.21037\/atm-22-5853","volume":"11","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Yuan X, Zhou Y, Chu L, Yang X, Ni J, Chu Q, Chu X, Liu Y, Zhu Z. The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study. Ann Transl Med. 2023;11(2):60.","journal-title":"Ann Transl Med"},{"issue":"7","key":"2783_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa071780","volume":"357","author":"B Slotman","year":"2007","unstructured":"Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E, Senan S. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357(7):664\u201372.","journal-title":"N Engl J Med"},{"issue":"2","key":"2783_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3904\/kjim.2022.361","volume":"38","author":"SH Kim","year":"2023","unstructured":"Kim SH, Jo EJ, Mok J, Lee K, Kim KU, Park HK, Lee MK, Eom JS, Kim MH. Real-world evaluation of Atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer. Korean J Intern Med. 2023;38(2):218\u201325.","journal-title":"Korean J Intern Med"},{"issue":"7","key":"2783_CR25","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s00066-023-02075-9","volume":"199","author":"E Hoffmann","year":"2023","unstructured":"Hoffmann E, De-Colle C, Potkrajcic V, Baumann D, Spengler W, Gani C, Utz D. Is consolidative thoracic radiotherapy of extensive-stage small cell lung cancer still beneficial in the era of immunotherapy? A retrospective analysis. Strahlenther Onkol. 2023;199(7):668\u201375.","journal-title":"Strahlenther Onkol"},{"issue":"8","key":"2783_CR26","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cllc.2023.08.009","volume":"24","author":"AJ Gross","year":"2023","unstructured":"Gross AJ, Sheikh S, Kharouta M, Chaung K, Choi S, Margevicius S, Fu P, Machtay M, Bruno DS, Dowlati A, et al. The impact of prophylactic cranial irradiation and consolidative thoracic radiation therapy for extensive stage Small-Cell lung cancer in the transition to the Chemo-Immunotherapy era: A single institution series. Clin Lung Cancer. 2023;24(8):696\u2013705.","journal-title":"Clin Lung Cancer"},{"key":"2783_CR27","doi-asserted-by":"publisher","first-page":"102795","DOI":"10.1016\/j.eclinm.2024.102795","volume":"75","author":"D Chen","year":"2024","unstructured":"Chen D, Zou B, Li B, Gao A, Huang W, Shao Q, Meng X, Zhang P, Tang X, Hu X, et al. Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trial. EClinicalMedicine. 2024;75:102795.","journal-title":"EClinicalMedicine"},{"issue":"11","key":"2783_CR28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.trecan.2016.09.007","volume":"2","author":"W Jiang","year":"2016","unstructured":"Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM. Immune priming of the tumor microenvironment by radiation. Trends Cancer. 2016;2(11):638\u201345.","journal-title":"Trends Cancer"},{"key":"2783_CR29","unstructured":"Zhu Z. A phase I dose escalation study of thoracic consolidation radiotherapy for extensive-stage small cell lung cancer patients treated with chemo-immunotherapy. 2024. https:\/\/www.clinicaltrials.gov\/study\/NCT06187740."}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-025-02783-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-025-02783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T01:27:35Z","timestamp":1769650055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-025-02783-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2783"],"URL":"https:\/\/doi.org\/10.1186\/s13014-025-02783-9","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"11 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received approval from the Institutional Ethics Committee of the Fudan University Shanghai Cancer Center (No. 2310284-2). Informed consent from individual patients was waived in this retrospective analysis. This study was conducted in line with the Declaration of Helsinki (as revised in 2013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Footnotes"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}